# United Community Banks Inc: financial statements, quarterly

UCB · NYSE · CIK 857855 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ucb.md) · [Financials](/companies/ucb/financials.md) · [Filings](/companies/ucb/filings.md) · [Insiders](/companies/ucb/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ucb/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [204](/filings/0000857855-24-000099.md) | [255 d](/filings/0000857855-26-000008.md) | [239](/filings/0000857855-25-000082.md) | [245](/filings/0000857855-25-000131.md) | [217](/filings/0000857855-25-000164.md) | [251 d](/filings/0000857855-26-000008.md) | [248](/filings/0000857855-26-000017.md) | [260](/filings/0000857855-26-000076.md) | [277](/filings/0000857855-25-000164.md) | [278 d](/filings/0000857855-26-000008.md) | [277](/filings/0000857855-26-000017.md) | [279](/filings/0000857855-26-000076.md) |
| Interest expense | $m | [121](/filings/0000857855-23-000063.md) | [135 d](/filings/0000857855-24-000010.md) | [138](/filings/0000857855-24-000017.md) | [138](/filings/0000857855-24-000059.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [11.9](/filings/0000857855-24-000099.md) | [(2.9) d](/filings/0000857855-26-000008.md) | [18.2](/filings/0000857855-25-000082.md) | [19.4](/filings/0000857855-25-000131.md) | [12.4](/filings/0000857855-25-000164.md) | [20.6 d](/filings/0000857855-26-000008.md) | [19.7](/filings/0000857855-26-000017.md) | [21.8](/filings/0000857855-26-000076.md) | [26.6](/filings/0000857855-25-000164.md) | [26.2 d](/filings/0000857855-26-000008.md) | [24.1](/filings/0000857855-26-000017.md) | [33.5](/filings/0000857855-26-000076.md) |
| Net income | $m | [47.9](/filings/0000857855-24-000099.md) | [14.1 d](/filings/0000857855-26-000008.md) | [62.6](/filings/0000857855-25-000082.md) | [66.6](/filings/0000857855-25-000131.md) | [47.3](/filings/0000857855-25-000164.md) | [75.8 d](/filings/0000857855-26-000008.md) | [71.4](/filings/0000857855-26-000017.md) | [78.7](/filings/0000857855-26-000076.md) | [91.5](/filings/0000857855-25-000164.md) | [86.5 d](/filings/0000857855-26-000008.md) | [84.3](/filings/0000857855-26-000017.md) | [116](/filings/0000857855-26-000076.md) |
| Diluted EPS | $ per share | [0.39](/filings/0000857855-24-000099.md) | not reported | [0.51](/filings/0000857855-25-000082.md) | [0.54](/filings/0000857855-25-000131.md) | [0.38](/filings/0000857855-25-000164.md) | not reported | [0.58](/filings/0000857855-26-000017.md) | [0.63](/filings/0000857855-26-000076.md) | [0.70](/filings/0000857855-25-000164.md) | not reported | [0.69](/filings/0000857855-26-000017.md) | [0.95](/filings/0000857855-26-000076.md) |
| Basic EPS | $ per share | [0.39](/filings/0000857855-24-000099.md) | not reported | [0.51](/filings/0000857855-25-000082.md) | [0.54](/filings/0000857855-25-000131.md) | [0.38](/filings/0000857855-25-000164.md) | not reported | [0.58](/filings/0000857855-26-000017.md) | [0.63](/filings/0000857855-26-000076.md) | [0.71](/filings/0000857855-25-000164.md) | not reported | [0.69](/filings/0000857855-26-000017.md) | [0.95](/filings/0000857855-26-000076.md) |

- Revenue: us-gaap:Revenues
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $bn | [26.9](/filings/0000857855-23-000063.md) | [27.3](/filings/0000857855-25-000057.md) | [27.4](/filings/0000857855-24-000017.md) | [27.1](/filings/0000857855-24-000059.md) | [27.4](/filings/0000857855-24-000099.md) | [27.7](/filings/0000857855-26-000008.md) | [27.9](/filings/0000857855-25-000082.md) | [28.1](/filings/0000857855-25-000131.md) | [28.1](/filings/0000857855-25-000164.md) | [28.0](/filings/0000857855-26-000076.md) | [28.2](/filings/0000857855-26-000017.md) | [29.1](/filings/0000857855-26-000076.md) |
| Total liabilities | $bn | [23.7](/filings/0000857855-23-000063.md) | [24.0](/filings/0000857855-25-000057.md) | [24.1](/filings/0000857855-24-000017.md) | [23.7](/filings/0000857855-24-000059.md) | [24.0](/filings/0000857855-24-000099.md) | [24.3](/filings/0000857855-26-000008.md) | [24.4](/filings/0000857855-25-000082.md) | [24.5](/filings/0000857855-25-000131.md) | [24.5](/filings/0000857855-25-000164.md) | [24.4](/filings/0000857855-26-000076.md) | [24.5](/filings/0000857855-26-000017.md) | [25.3](/filings/0000857855-26-000076.md) |
| Long-term debt | $bn | [0.3](/filings/0000857855-23-000063.md) | [0.3](/filings/0000857855-25-000057.md) | [0.3](/filings/0000857855-24-000017.md) | [0.3](/filings/0000857855-24-000059.md) | [0.3](/filings/0000857855-24-000099.md) | [0.3](/filings/0000857855-26-000008.md) | [0.3](/filings/0000857855-25-000082.md) | [0.2](/filings/0000857855-25-000131.md) | [0.2](/filings/0000857855-25-000164.md) | [0.1](/filings/0000857855-26-000076.md) | [0.1](/filings/0000857855-26-000017.md) | [0.0](/filings/0000857855-26-000076.md) |
| Short-term borrowings | $bn | [0.0](/filings/0000857855-23-000063.md) | [0.0](/filings/0000857855-25-000057.md) | not reported | not reported | not reported | [0.2](/filings/0000857855-26-000008.md) | [0.0](/filings/0000857855-25-000082.md) | [0.0](/filings/0000857855-25-000131.md) | [0.0](/filings/0000857855-25-000164.md) | [0.1](/filings/0000857855-26-000076.md) | [0.0](/filings/0000857855-26-000017.md) | [0.4](/filings/0000857855-26-000076.md) |
| Shareholders' equity | $bn | [3.2](/filings/0000857855-24-000099.md) | [3.3](/filings/0000857855-26-000008.md) | [3.3](/filings/0000857855-25-000131.md) | [3.3](/filings/0000857855-25-000164.md) | [3.4](/filings/0000857855-25-000164.md) | [3.4](/filings/0000857855-26-000076.md) | [3.5](/filings/0000857855-26-000076.md) | [3.6](/filings/0000857855-26-000076.md) | [3.6](/filings/0000857855-25-000164.md) | [3.6](/filings/0000857855-26-000076.md) | [3.7](/filings/0000857855-26-000076.md) | [3.7](/filings/0000857855-26-000076.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [87.2 d](/filings/0000857855-24-000099.md) | [21.8 d](/filings/0000857855-26-000008.md) | [88.8](/filings/0000857855-25-000082.md) | [105 d](/filings/0000857855-25-000131.md) | [7.7 d](/filings/0000857855-25-000164.md) | [148 d](/filings/0000857855-26-000008.md) | [98.6](/filings/0000857855-26-000017.md) | [96.8 d](/filings/0000857855-26-000076.md) | [123 d](/filings/0000857855-25-000164.md) | [65.5 d](/filings/0000857855-26-000008.md) | [69.3](/filings/0000857855-26-000017.md) | [131 d](/filings/0000857855-26-000076.md) |
| Capital expenditure | $m | [15.3 d](/filings/0000857855-24-000099.md) | [13.3 d](/filings/0000857855-26-000008.md) | [13.7](/filings/0000857855-25-000082.md) | [17.9 d](/filings/0000857855-25-000131.md) | [9.9 d](/filings/0000857855-25-000164.md) | [5.5 d](/filings/0000857855-26-000008.md) | [4.3](/filings/0000857855-26-000017.md) | [12.1 d](/filings/0000857855-26-000076.md) | [5.4 d](/filings/0000857855-25-000164.md) | [5.8 d](/filings/0000857855-26-000008.md) | [6.9](/filings/0000857855-26-000017.md) | [9.2 d](/filings/0000857855-26-000076.md) |
| Dividends paid | $m | [26.9 d](/filings/0000857855-24-000099.md) | [27.7 d](/filings/0000857855-26-000008.md) | [27.7](/filings/0000857855-25-000082.md) | [27.8 d](/filings/0000857855-25-000131.md) | [27.8 d](/filings/0000857855-25-000164.md) | [29.0 d](/filings/0000857855-26-000008.md) | [29.1](/filings/0000857855-26-000017.md) | [29.1 d](/filings/0000857855-26-000076.md) | [29.5 d](/filings/0000857855-25-000164.md) | [30.8 d](/filings/0000857855-26-000008.md) | [30.6](/filings/0000857855-26-000017.md) | [30.4 d](/filings/0000857855-26-000076.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | [0.0 d](/filings/0000857855-25-000164.md) | [0.0 d](/filings/0000857855-26-000008.md) | [0.0](/filings/0000857855-26-000017.md) | [13.9 d](/filings/0000857855-26-000076.md) | [0.0 d](/filings/0000857855-25-000164.md) | [30.3 d](/filings/0000857855-26-000008.md) | [37.1](/filings/0000857855-26-000017.md) | [0.0 d](/filings/0000857855-26-000076.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [107](/filings/0000857855-23-000063.md) | [116](/filings/0000857855-24-000017.md) | [116](/filings/0000857855-24-000059.md) | [120](/filings/0000857855-24-000099.md) | [120](/filings/0000857855-25-000082.md) | [120](/filings/0000857855-25-000131.md) | [120](/filings/0000857855-25-000164.md) | [120](/filings/0000857855-26-000017.md) | [121](/filings/0000857855-26-000076.md) | [122](/filings/0000857855-25-000164.md) | [121](/filings/0000857855-26-000017.md) | [120](/filings/0000857855-26-000076.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 120,575,503 at 2026-08-03, from the cover of the [10-Q filed 2026-08-05](/filings/0000857855-26-000076.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:26 ET. No prices; not investment advice.